| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CHPT | Common Stock | Sale | -$44.1K | -4.84K | -100% | $9.11 | 0 | Jun 15, 2023 | See footnotes | F2, F4 |
| transaction | CHPT | Common Stock | Sale | -$3.69M | -408K | -19.43% | $9.06 | 1.69M | Jun 15, 2023 | See footnotes | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.0624 to $9.125, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| F2 | Consists of securities held directly by Levitate Capital GP LP ("Levitate GP"). Linse Capital Management PR LLC ("LCMPR") is the general partner of Levitate GP. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has voting and investment power over the shares held by Levitate GP. |
| F3 | Consists of securities held directly by Linse Capital LLC. Mr. Linse is the managing director of Linse Capital LLC. Mr. Linse has sole voting and investment power over the shares held by Linse Capital LLC. |
| F4 | Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. |